Skip Navigation

Toxicological Sciences 2007 100(1):5-6; doi:10.1093/toxsci/kfm228
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stachlewitz, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stachlewitz, R. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Bringing Biomarkers to the Masses: An Elegant Approach to Discover Potential Biomarkers of Vascular Injury

Robert Francis Stachlewitz1

Toxicology and Safety Assessment, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877

1 For correspondence via. Fax: +203 798 5797. e-mail: rstachle@rdg.boehringer-ingelheim.com.

Received August 28, 2007; accepted August 28, 2007

The first 10% of the full text of this article appears below.

One of the greatest criticisms of scientists is that many do a poor job conveying the importance of their work to the public. My graduate professor used to say that one should be able to take their research project and "tell a story that even your Grandmother could understand." This statement was certainly not meant as a derogatory comment toward all of the grandmothers in the world. This was his "not-so politically correct" way of saying that we all need to think about a concise story, devoid of scientific jargon, to describe our research to the public. We have all had projects where the layperson's description was difficult to develop because of the complexity or proprietary nature of the work. However, the development of biomarkers of toxicity is one of the areas where the complexity of the science can be readily distilled to a concise story highlighting that one . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?